TNF and hepatocellular carcinoma: Moreover, in HCC (BNL and Hepa 1–6) tumor models, we showed that entolimod prevented mouse mortality caused by TNF combined with D-galactosamine (D-GalN) sensitization but did not diminish tumor growth suppression.